TIDMMSYS
Microsaic Systems plc
25 May 2021
Reach
25 May 2021
Microsaic Systems plc
("Microsaic" or the "Company")
Joint development of 'Forever Chemicals' detection platform with
Swansea University and Investor Presentation
Microsaic equipment used for environmental monitoring, to inform
the links between environmental pollution and public health.
Microsaic (AIM: MSYS), the developer of point of need mass
spectrometry ("MS") instruments, is delighted to announce a
collaboration with Swansea University Medical School, utilising
Microsaic's miniature mass spectrometry equipment, to develop a
monitoring platform capable of measuring per- and polyfluoroalkyl
substances ("PFAS", also known as 'forever chemicals') at source
and within a laboratory setting. This will be used to establish the
health impacts of the broader range of PFAS pollutants. The
detection platform will combine environmental sample preparation
and epigenetic approaches with Microsaic's miniature mass
spectrometer. Through partnership with stakeholders in the
environmental sector, this collaboration is designed to better
inform pollution remediation, improve management processes for
reduced emission and promote safer handling of PFAS chemicals.
PFAS are pollutants of increasing concern, known as 'forever
chemicals' given their environmental persistence following use as
protective, non-stick and fire-retardant coatings within
electronics, textiles, cleaning agents and cookware(1) . There is a
shortage of environmental testing globally yet initial human
epigenetic studies show reproductive, developmental, liver, kidney,
and immunological effects(1,2,3) from skin contact or contaminated
food or water, meaning there is an increasing need to monitor these
pollutants. Furthermore, given there are conflicting accounts of
the epigenetic mechanisms of specific PFAS (e.g. DNA methylation
with PFOS and PFOA)(3,4) , questions remain as to how epigenetic
changes occur across the chemical breadth and for mixtures of PFAS
pollutants.
Environmental pollution has been strongly linked to adverse
human health outcomes, prompting growing research activity to
determine how this leads to disease. Given the breadth of chemicals
used in everyday life and their resistance to environmental
breakdown, the risk of pollution following release via production,
use, ineffective wastewater remediation, and/or leachate from
landfill is significant.
Glenn Tracey, CEO of Microsaic Systems plc, commented:
" Establishing 'Fit-for-purpose' monitoring approaches is
critical to understanding better which pollutants are present, the
degree of exposure to and risk posed by such pollutants, and
efficacy of management processes to control how they are released
and to mitigate harm better. Current monitoring approaches
typically require individual sample collection onsite, with sample
preparation and analysis using complex instrumentation in a remote
laboratory, resulting in delayed deployment of mitigation
measures.
We believe that the world needs remote monitoring solutions that
provide real-time data of chemical pollution, to inform automated
or other process management or clean-up processes, for reduced
environmental and public health impact.
I am delighted that Microsaic's point of need technology are
being used in this effort to drive improvements in online
environmental monitoring and ground-breaking research to help
inform the links between environmental pollutants and their effects
on the human genome."
Investor Presentation
Microsaic is pleased to announce that Glenn Tracy, CEO of the
Company, will provide a live presentation relating to the
development of the 'Forever Chemicals' detection platform with
Swansea University via the Investor Meet Company platform on 27 May
2021 at 4:30pm BST.
The presentation is open to all existing and potential
shareholders. Questions can be submitted pre-event via the Investor
Meet Company dashboard up until 9:00am the day before the meeting
or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add
to meet Microsaic Systems plc via:
https://www.investormeetcompany.com/microsaic-systems-plc/register-investor
Investors who already follow Microsaic Systems plc on the
Investor Meet Company platform will automatically be invited.
References:
(1) EPA,
https://www.epa.gov/pfas/basic-information-pfas#difference
(2) Toxicology Department CRCE, PHE 2009 Version 1 , PFOS and
PFOA: General Information
(3) Kim, S,., Thapar, I., Brooks, B. W., Epigenetic changes by
per- and polyfluoroalkyl substances (PFAS). 2021. Env. Pol. 279: p.
116929.
(4) Kingsley, S.L., Kelsey, K.T., Butler, R., Chen, A., Eliot,
M.N., Romano, M.E., et al., 2017. Maternal serum PFOA concentration
and DNA methylation in cord blood: a pilot study. Environ. Res.
158, 174e178. etc
Enquiries:
Microsaic Systems plc
Glenn Tracey, CEO
Bevan Metcalf, FD +44 (0)1483 751 577
N+1 Singer (Nominated Adviser & Joint
Broker) +44 (0)20 7496 3000
Aubrey Powell / George Tzimas (Corporate
Finance)
Tom Salvesen (Corporate Broking)
Turner Pope Investments (TPI) Limited
(Joint Broker)
James Pope +44 (0) 20 3657 0050
About Microsaic (www.microsaic.com)
Microsaic listed on AIM in 2011 to develop and commercialise
micro-engineering chip-based mass spectrometry equipment. Having
invested GBP30m over the last 20 years before and after the IPO,
Microsaic has a robust patent portfolio in cutting-edge technology
purpose built for "Industry 4.0" which enables analytical detection
and characterisation at the point-of-need, whether within a human
health environment, conventional laboratory setting, or within a
bioprocessing facility for continuous mass spectrometer detection
and monitoring of data at any step in the process workflow.
Microsaic's products and systems are commercially available
through global markets via a network of regional and local
partners, targeting its core laboratory, manufacturing and
point-of-need applications.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAVZLFLFELZBBL
(END) Dow Jones Newswires
May 25, 2021 02:00 ET (06:00 GMT)
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From Apr 2024 to May 2024
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From May 2023 to May 2024